Abstract
AbstractChondrosarcomas, malignant cartilaginous neoplasms, are capable of transitioning to highly aggressive, metastatic, and treatment-refractory states, resulting in significant patient mortality. Here, we aim to uncover the transcriptional program directing such tumor progression in chondrosarcomas. We conduct weighted correlation network analysis to extract a characteristic gene module underlying chondrosarcoma malignancy. Hypoxia-inducible factor-2α (HIF-2α, encoded by EPAS1) is identified as an upstream regulator that governs the malignancy gene module. HIF-2α is upregulated in high-grade chondrosarcoma biopsies and EPAS1 gene amplification is associated with poor prognosis in chondrosarcoma patients. Using tumor xenograft mouse models, we demonstrate that HIF-2α confers chondrosarcomas the capacities required for tumor growth, local invasion, and metastasis. Meanwhile, pharmacological inhibition of HIF-2α, in conjunction with the chemotherapy agents, synergistically enhances chondrosarcoma cell apoptosis and abolishes malignant signatures of chondrosarcoma in mice. We expect that our insights into the pathogenesis of chondrosarcoma will provide guidelines for the development of molecular targeted therapeutics for chondrosarcoma.
Funder
National Research Foundation of Korea
Ministry of Science, ICT and Future Planning
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference77 articles.
1. Bovee, J. V., Hogendoorn, P. C., Wunder, J. S. & Alman, B. A. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat. Rev. Cancer 10, 481–488 (2010).
2. Gelderblom, H. et al. The clinical approach towards chondrosarcoma. Oncologist 13, 320–329 (2008).
3. Kim, M. J., Cho, K. J., Ayala, A. G. & Ro, J. Y. Chondrosarcoma: with updates on molecular genetics. Sarcoma 2011, 405437 (2011).
4. Bovee, J. V., Cleton-Jansen, A. M., Taminiau, A. H. & Hogendoorn, P. C. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol. 6, 599–607 (2005).
5. Malchenko, S. et al. Putative multifunctional signature of lung metastases in dedifferentiated chondrosarcoma. Sarcoma 2012, 820254 (2012).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献